64.6 F
New York
Thursday, October 22, 2020

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Sets the Stage for 2017

Must read

Hexcel Corporation (NYSE:HXL) Finding Zero Support

Hexcel Corporation (HXL) shares are trading at lower $34.10 and the avg recommendation for the stock is Hold, while the current analyst price target...

Equitrans Midstream Corporation (NYSE:ETRN) on the Path to Profitability

Equitrans Midstream Corporation (ETRN) shares are trading at higher $8.27 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

The Unprecedented Rise of Callon Petroleum Company (NYSE:CPE)

Callon Petroleum Company (CPE) shares are trading at higher $4.73 and the avg recommendation for the stock is Hold. To add more color to...

Investor Confidence is Rising for China Pharma Holdings Inc. (AMEX:CPHI)

China Pharma Holdings Inc. (CPHI) shares are trading at higher $0.46 and the avg recommendation for the stock is Moderate Buy. To add more...

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is a micro-cap medical marijuana play that has some monster gains under its belt over the past few weeks. And traders have certainly taken notice. Management just hit the wires with its annual letter to the Company’s shareholders to further stoke the flames of enthusiasm for this pre-revenue play.

Perhaps most important to note in the letter were the anticipated action items the company would be looking forward to in 2017: 1. During the second quarter of 2017 OWCP intends to initiate its U.S marketing program for its Psoriasis Topical Cream. At the same time, we intend to begin investigating the applicability of topical cream for other skin conditions and disorders. 2. OWCP intends to proceed with the advancement of our cannabis-based treatment for multiple myeloma, with the objective of proceeding with additional studies. And 3. OWCP intends to evaluate the launch of one or more studies to determine the applicability of cannabinoid-based pharmaceuticals for other medical conditions and disorders, such as fibromyalgia and migraines.

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) bills itself as a company that engages in the research and development of Cannabis-based medical products. The company provides medical products for the treatment of various medical conditions and/or diseases, such as multiple myeloma, psoriasis, PTSD, and migraines; and delivery systems. It also provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations.

OWCP through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., conducts medical research and clinical trials to develop cannabis-based pharmaceuticals, treatments and unique delivery systems for the effective delivery and dosage of medical cannabis.

All OWC research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators.

The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids in the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.

The Company is a wholly owned subsidiary of OWC Pharmaceutical Research Corp. The company was formerly known as Dynamic Applications Corp. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Petach Tikva, Israel.

According to company materials, “OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., (collectively “OWC” or the “Company”) conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. OWC is also developing unique delivery systems for the effective delivery and dosage of medical cannabis. All OWC research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators. The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids for the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.”

Find out when $OWCP stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Mordechai Bignitz, CEO, concluded the letter with the following passage: “We are very pleased with the progress that OWCP made during 2016, and look forward to further significant accomplishments in 2017. Most importantly, we’re looking forward to beginning the commercial sales of our psoriasis cream, which will hopefully be launched in the United States and Europe.

“We are also pleased that OWCP was able to receive a $300,000 non-dilutive loan from Medmar to be repaid from royalties from the sale of OWC’s psoriasis cream in the U.S. The $300,000 investment fromMichepro Holding for OWCP’s products in Europe, is significant as it also establishes a joint venture company in Europe, owned by Michepro and OWCP, to manufacture and distribute OWCP’s products, starting with our psoriasis cream for the European market. OWCP will continue to update and keep you informed regarding our progress this year. Best wishes for 2017.”

We’ve witnessed more than 270% tacked on to share pricing for the company in the past month. Market participants may want to continue to pay attention to this stock as it has also benefitted from a jump in recent trading volume to the tune of 45% beyond its prior sustained average level during this intense rally.

Currently trading at a market capitalization of $93.3M, OWCP has about $90K in cash on the books, which must be weighed relative to about $186K in total current liabilities. The company is pre-revenue at this point. You can bet we will update this one again as new information comes into view. For continuing coverage on shares of OWCP stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!

Latest article

Is Now the Time to Invest in Two Harbors Investment Corp. (NYSE:TWO)?

Two Harbors Investment Corp. (TWO) shares are trading at higher $5.21 and the avg recommendation for the stock is Moderate Buy, while the current...

Patterson-UTI Energy Inc. (NASDAQ:PTEN) Stock is Soaring, Here is Why

Patterson-UTI Energy Inc. (PTEN) shares are trading at higher $2.68 and the avg recommendation for the stock is Hold, while the current analyst price...

Costamare Inc. (NYSE:CMRE) is Holding Steady

Costamare Inc. (CMRE) shares are trading at higher $7.38 and the avg recommendation for the stock is Strong Buy, while the current analyst price...

Investor Confidence is Falling for DocuSign Inc. (NASDAQ:DOCU)

DocuSign Inc. (DOCU) shares are trading at lower $227.80 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Seanergy Maritime Holdings Corp. (NASDAQ:SHIP) is Gaining Momentum on Earnings Catalyst

Seanergy Maritime Holdings Corp. (SHIP) shares are trading at lower $0.44 and the avg recommendation for the stock is Hold. To add more color...